Applications of Z-D-His-OH in Industrial Manufacturing

Z-D-His-OH, as a protected histidine derivative, finds practical deployment in peptide synthesis and related specialty chemistry. The following application scenarios highlight established downstream workflows, compliance parameters, formulation knowledge, and finished product types managed by our industrial partners.

1. Solid-Phase Peptide Synthesis (SPPS) for Active Pharmaceutical Ingredients

Pharmaceutical manufacturers rely on Z-D-His-OH during SPPS processes to construct therapeutic peptides, especially where precise protection of the imidazole side chain is required to prevent undesired reactions. The use of this raw material aligns with the controlled introduction of histidine residues in peptide APIs, enabling consistency throughout multi-step couplings and deprotection cycles. Accurate tracking and adjustment of loading ratios in resin-based protocols directly affect peptide yield and purity, impacting both process economics and regulatory compliance.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP) for APIs (21 CFR Parts 210 & 211, EU GMP Part II)
• ICH Q7 Guideline: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP/NF Monographs for peptide-based drugs
• Relevant pharmacopoeial guidelines depending on API market

Typical usage ratio

• Concentration typically ranges from 1 to 1.2 molar equivalents relative to the resin’s loading site;
• Precise ratio depends on desired coupling efficiency, peptide sequence, and resin characteristics

Downstream process integration

• Z-D-His-OH is introduced at the histidine coupling step within automated or manual solid-phase peptide synthesis cycles, often following initial resin swelling and pre-activation, and is subsequently deprotected after elongation

Final product types

• Peptide Active Pharmaceutical Ingredients (APIs), including oligopeptides for injectable therapeutics, oral peptide drugs, and custom peptide sequences for research

2. Cosmetic Bioactive Peptides Manufacturing

The material supports the scalable assembly of bioactive peptide sequences used in personal care cosmeceuticals, particularly those with antioxidative or anti-aging functionality attributed to histidine residues. Stringent traceability and allergen management underpin regulatory documentation, while the stability of the histidine side chain throughout synthesis and downstream formulation ensures compliance and consistent batch performance.

Industry compliance standards

• ISO 22716: Cosmetic GMP
• EU Cosmetics Regulation (EC) No. 1223/2009
• IFRA Standards for peptide safety where fragrance overlap occurs
• REACH Registration, where applicable, for peptide ingredients

Typical usage ratio

• Generally 0.85–1.15 molar equivalents per designated coupling site for cosmetic peptides; fine-tuned according to desired bioactivity and peptide purity

Downstream process integration

• Z-D-His-OH is dosed at the histidine coupling phase within semi-automated SPPS lines, followed by side chain deprotection and purification before formulation into finished cosmetic actives

Final product types

• Anti-aging skin creams and serums, peptide-enriched masks, functional cosmetic actives blended for dermal health claims

3. Synthesis of Diagnostic Peptide Reagents

Peptide reagents with site-protected histidine are central to immunoassay development, clinical diagnostics, or biosensor applications. Manufacturers must ensure accurate building block traceability and validated raw material handling to protect assay reproducibility across production campaigns, thereby upholding assay specificity and reliability during quality control.

Industry compliance standards

• EN ISO 13485: Quality Management for Medical Devices
• IVD Directive 98/79/EC and IVDR (EU 2017/746)
• ANSI/AAMI/ISO 14971: Risk Management for medical devices
• Supplier audit and approval procedures per customer QMS

Typical usage ratio

• Ranging between 0.95–1.10 equivalents per peptide unit during sequence elongation; tuning based on desired reagent-binding affinity and platform requirements

Downstream process integration

• Material is incorporated at the histidine addition stage, preserved during subsequent rounds of coupling and partial deprotection, then cleaved for conjugation or immobilization in diagnostic device assembly

Final product types

• Peptide-based immunoassay reagents, calibration standards, in vitro diagnostic test components, and biosensor coatings

4. Custom Peptide Synthesis Services for R&D and Preclinical Models

Contract research organizations and advanced laboratory suppliers increasingly require protected histidine intermediates to craft high-purity peptides for biomedical research, structure-activity studies, and preclinical validation. Material specification, batch reproducibility, and technical data traceability are central during procurement, as customers demand that even small-scale supply batches mirror cGMP and ISO documentation for seamless project handover.

Industry compliance standards

• ISO 9001:2015 Quality Management System
• GLP standards for preclinical research raw materials
• Customer-specific RFQ and technical agreement specifications
• Documentation per OECD Principles of Good Laboratory Practice

Typical usage ratio

• Standard charge of 1.0 molar equivalent per coupling step, modifying loading based on chain length, solid support type, and scale (mg to gram quantities)

Downstream process integration

• Batch addition during sequence assembly on solid support, followed by sequence-specific cleavage and analytical verification prior to release for life science or preclinical study applications

Final product types

• Custom research peptides, labeled peptide standards for mass spectrometry, tool compounds for cellular pathway studies, and exploratory peptide candidates